Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64.2Revenue $M1.2Net Margin (%)-2,530.4Z-Score-13.4
Enterprise Value $M48.0EPS $-0.6Operating Margin %-2,662.5F-Score2
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)-2,530.4Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %-14.5Quick Ratio4.3Cash flow > EarningsY
Price/Sales46.55-y EBITDA Growth Rate %-31.5Current Ratio4.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-81.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-374.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M68.7ROI % (ttm)-260.8Gross Margin Increase y-yN

Gurus Latest Trades with STEM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

STEM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


STEM: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about STEM :

    Quarterly/Annual Reports about STEM:

    News about STEM:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    comment on STEM Feb 09 2012 
    Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
    StemCells Inc. Reports Operating Results (10-Q) Nov 03 2010 
    StemCells Inc. Reports Operating Results (10-Q) May 04 2010 
    StemCells Inc. Reports Operating Results (10-Q) Nov 05 2009 
    StemCells, Inc. Reports Second Quarter Financial Results Aug 10 2009 
    StemCells Inc. Reports Operating Results (10-Q) Aug 10 2009 
    The Next Boom Emerges Nov 23 2008 

    More From Other Websites
    REUTERS AMERICA NEWS PLAN FOR THURSDAY DEC 18 Dec 18 2014
    StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord... Dec 18 2014
    StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord... Dec 18 2014
    STEMCELLS INC Files SEC form 8-K, Termination of a Material Definitive Agreement Dec 12 2014
    StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event Dec 02 2014
    StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event Dec 02 2014
    STEMCELLS INC Financials Nov 21 2014
    StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York Nov 20 2014
    StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York Nov 20 2014
    10-Q for StemCells, Inc. Nov 15 2014
    STEMCELLS INC Files SEC form 10-Q, Quarterly Report Nov 13 2014
    STEMCELLS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014
    StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results Nov 05 2014
    StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results Nov 05 2014
    StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York Nov 03 2014
    StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York Nov 03 2014
    StemCells Starts Phase II Cervical Spinal Cord Injury Study Oct 08 2014
    STEMCELLS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 08 2014
    StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury Oct 07 2014
    StemCells, Inc. to Participate at the 2014 Stem Cell Meeting on the Mesa Oct 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK